Background: Spirulina is one of the most profitable known microalgae in the world, which is used as food and superfood. In the other hand, Spirulina is a useful source of healthy components. It seems that the Spirulina is transformable so that the introduction of a selectable marker is needed. Objectives: The purpose of this study was to determine a suitable selection marker for Spirulina platensis. Thus, this experiment was designed to survey the response of Spirulina to different concentrations of candidate antibiotics including kanamycin, hygromycin, phosphinothricin, chloramphenicol and streptomycin in standard Zarrouk medium. Materials and Methods: S. platensis culture matched to 1 McFarland standard and its resistance to different antibiotics was studied by serial dilution of kanamycin, hygromycin, phosphinothricin, chloramphenicol and streptomycin. Biomass was detected after 7days using spectrophotometer and related growth graphs were illustrated. Results: Fresh culture of S. platensis reached to exponential phase on day 4 of experiment. While this phase was presented on day 5 for cultures containing kanamycin or hygromycin. The Spirulina cultured in medium supplied with basta, did not reach to growth phase however, chloramphenicol can stop the growth of Spirulina cells. Spirulina showed resistance to streptomycin with the concentration of 40 mg/L and higher. Therefore, streptomycin can use as selectable marker to detect GM (Genetic Modified) Spirulina spp. Conclusions:The streptomycin can be used as suitable selection marker in comparison with other introduced markers. For using this selectable marker, integration of a streptomycin resistant gene is needed. The gene aadA is a potential candidate. The aadA gene can be expressed under the control of upstream and downstream elements of S. platensis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.